Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Identify what to focus on for retirement in your 40s. Stay proactive in securing your financial well-being as you age.
22,435 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Rivian’s shares fell roughly 5% after unveiling the R2, erasing prior gains as the market assesses the mass-market pr...
A fresh examination of the innovations powering U.S. military dominance and how investors are pricing defense names i...
Federal officials order a Texas-based oil company to resume offshore California production under the Defense Producti...
A once-observed signal is flashing green again: the metric that preceded every BTC rally has appeared, as negative fu...
In 2026, a disciplined trio of growth ETFs offers a clear path to long-term wealth through earnings-driven expansion,...
Sunway Healthcare opened sharply higher on its first trading day after a multi-billion ringgit IPO, reflecting growin...
Block, Palantir, Atlassian, and Salesforce are in the spotlight as layoffs and hiring pauses test how cost cuts affec...
Alibaba.com's leader previews a future where a single founder can run a global B2B business with AI handling the heav...
Moldova's parliament approved a 60-day energy emergency following Russian strikes on Ukraine's grid that cut the Isac...
A notorious short-seller unloaded sofi this week with sweeping accusations, but the stock shrugged off most of the blow.
Morgan Stanley cuts Li Auto to a $22 price target while maintaining an upbeat view on margin recovery tied to the L9 ...